Heidi Anne

Heidi Anne is a journalist with a focus on mental health and psychiatry. She has covered various aspects of the field, including the latest research, treatments, and policy issues. Heidi is passionate about providing accurate and informative reporting on mental health topics to help raise awareness and reduce stigma. In addition to her work in journalism, Heidi has also been involved in advocacy efforts for improved mental health care. Heidi holds a degree in Journalism from XYZ University and has completed numerous courses on mental health issues. She is a member of the Society of Professional Journalists and the National Alliance on Mental Illness.

Biography:  https://www.psychiatrictimes.com/view/behind-bars-an-insider-s-perspective-on-correctional-psychiatry

64%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

50%

Examples:

  • Numerous studies have illuminated the complications associated with GLP-1 medication in patients with psychological disorders.
  • Poster aims to improve awareness of the potential risk of suicidal ideation in patients taking semaglutide.
  • She also attempted self-strangulation more than once. These behavioral changes ameliorated after discontinuing the weight loss agent.

Conflicts of Interest

100%

Examples:

  • Numerous studies have illuminated the complications associated with GLP-1 medication in patients with psychological disorders.
  • Poster aims to improve awareness of the potential risk of suicidal ideation in patients taking semaglutide.
  • She also attempted self-strangulation more than once. These behavioral changes ameliorated after discontinuing the weight loss agent.

Contradictions

100%

Examples:

  • Approximately 60 documented cases of suicidal ideation and 7 suicide attempts associated with semaglutide use in patients.
  • Poster aims to improve awareness of the potential risk of suicidal ideation in patients taking semaglutide.
  • Within 3 weeks of initiating the medication, the patient began to experience significant psychiatric disturbances including abrupt behavioral alterations and protracted nihilistic delusions. She also attempted self-strangulation more than once.

Deceptions

30%

Examples:

  • Approximately 60 documented cases of suicidal ideation and 7 suicide attempts associated with semaglutide use in patients.
  • Poster aims to improve awareness of the potential risk of suicidal ideation in patients taking semaglutide.
  • Within 3 weeks of initiating the medication, the patient began to experience significant psychiatric disturbances including abrupt behavioral alterations and protracted nihilistic delusions. She also attempted self-strangulation more than once.

Recent Articles

GLP-1 Receptor Agonists and Psychiatric Issues: Two Cases of Depression and Suicidal Ideation Linked to Semaglutide

GLP-1 Receptor Agonists and Psychiatric Issues: Two Cases of Depression and Suicidal Ideation Linked to Semaglutide

Broke On: Wednesday, 08 May 2024 Two case studies presented at the American Psychiatric Association annual meeting suggest a potential link between GLP-1 receptor agonists like semaglutide and psychiatric issues, including depression and suicidal ideation. The medication, which acts on the brain to modulate food intake and reward, has been associated with approximately 60 reported cases of suicidal ideation since 2018. Further research is needed to identify specific proteins or enzymes that may exacerbate psychological conditions and contribute to these risks.